Intracellular Staphylococcus aureus: live-in and let die, Cell Infect Microbiol, vol.2, p.43, 2012. ,
New in vitro and in vivo models to 5 evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection, J 6 Antimicrob Chemother, vol.71, pp.1291-1300, 2016. ,
Comparative efficacies of human simulated exposures 8 of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a 9 range of vancomycin MICs in a murine pneumonia model, Antimicrob Agents Chemother, vol.10, pp.5115-5124, 2010. ,
Pharmacodynamic profile of daptomycin 12 against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine 13 thigh infection model, J Antimicrob Chemother, vol.52, pp.405-416, 2003. ,
Monitoring in vivo fitness of rifampicin-resistant 15 ,
, Staphylococcus aureus mutants in a mouse biofilm infection model, J Antimicrob Chemother, vol.16, pp.528-562, 2005.
Impact of vancomycin on sarA-mediated biofilm 18 formation: role in persistent endovascular infections due to methicillin-resistant 19 Staphylococcus aureus, J Infect, vol.209, pp.1231-1271, 2014. ,
The in vivo biofilm, Trends Microbiol, vol.21, pp.466-74, 2013. ,
Quantifying the natural 23 history of biofilm formation in vivo during the establishment of chronic implant, p.24 ,
, Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors, J 25 Orthop Res, vol.33, pp.1311-1320, 2015.
Impact of selective antimicrobial 27 agents on staphylococcal adherence to biomedical devices, Am J Surg, vol.192, p.10, 2006. ,
Outcome and predictors of treatment failure in 29 total hip/knee prosthetic joint infections due to Staphylococcus aureus, Antimicrob Agents Chemother, vol.30, p.12, 2009. ,
Efficacy of high doses of daptomycin versus 34 alternative therapies against experimental foreign-body infection by methicillin-resistant 35 Staphylococcus aureus, Antimicrob Agents Chemother, vol.53, pp.4252-4259, 2009. ,
Comparison of biofilm-associated cell survival 37 following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the 38 antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin, Int J Antimicrob 39 Agents, vol.33, pp.374-382, 2009. ,
Efficacy of daptomycin combined with 41 rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus 42 (MRSA) acute osteomyelitis, Int J Antimicrob Agents, vol.36, p.15, 2010. ,
New insight into daptomycin bioavailability 44 and localization in Staphylococcus aureus biofilms by dynamic fluorescence imaging ,
, Antimicrob Agents Chemother, vol.60, pp.4983-90, 2016.
Delta-toxin production deficiency in 1 Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with 2 osteoblast invasion and biofilm formation, Staphylococcus aureus Biofilms Induce, vol.21, pp.568-569, 2015. ,
, Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin. mBio, vol.6, p.18, 2015.
Daptomycin and rifampin alone and in 6 combination prevent vascular graft biofilm formation and emergence of antibiotic resistance 7 in a subcutaneous rat pouch model of staphylococcal infection, Eur J Vasc Endovasc, vol.8, pp.817-839, 2010. ,
Mechanism of late prosthetic vascular graft 10 infection, Cardiovasc Surg, vol.5, pp.486-495, 1997. ,